Study to Compare Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesion Barrier
Randomised, Controlled Clinical Study With Patients With Endometriosis and the Desire to Have Children - Comparison Between Peritoneal Ablation by Excision Only and Excision With the Use of an Adhesionbarrier
1 other identifier
interventional
60
1 country
1
Brief Summary
Endometriosis is a common disease of women in the reproductive age and is an important cause for female infertility. Endometriosis is often associated with the development of adhesions which further compromises the fertility of the affected women. The main purpose of this study is to investigate the pregnancy rate one year after excision of endometriosis and application of GnRH-analogues (Gonadotropin-releasing hormone) for 3 month. Half of the patients will receive traditional endometriosis treatment with the excision of the endometriotic lesions only. The other half will additionally receive a gel which can reduce adhesion formation (Hyalobarrier®). Further study objective is the investigation in the development of different types of endometriosis-associated pain over a period of one year. Potential study participants are women with endometriosis-associated pain and with a desire to have children. It will be investigated in the study if the use of Hyalobarrier® will result in a higher pregnancy rate due to reduced adhesion development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started May 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2014
CompletedFirst Posted
Study publicly available on registry
June 18, 2014
CompletedStudy Start
First participant enrolled
May 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedNovember 3, 2015
November 1, 2015
2 years
April 15, 2014
November 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pregnancy rate
One year after completion of endometriosis treatment (excision followed by 3 month of GnRH-analogues)
Secondary Outcomes (2)
Endometriosis-associated pain
The day before laparoscopy is performed
Endometriosis-associated pain
One year after completion of endometriosis treatment
Study Arms (2)
Excision only
PLACEBO COMPARATORLaparoscopic excision of endometriotic lesions followed by 3 month of GnRH-Analogue administration
Excision plus hyaluronic acid gel
ACTIVE COMPARATORStandard Laparoscopic excision of endometriotic lesions plus application of 10 cc of a hyaluronic acid gel (Hyalobarrier® ), followed by 3 month of GnRH-analogue administration
Interventions
Excision of endometriosis foci by laparoscopic standard methods followed by an application of 10 cc Hyaluronic acid gel, in order to prevent postsurgical adhesions.
Excision of endometriosis foci by laparoscopic standard methods only.
Eligibility Criteria
You may qualify if:
- Participants are in good general health except for endometriosis related problems;
- Except for endometriosis, no existence of an obvious diseases which could cause chronic pain or which could cause abdominal pain;
- The participant must have a desire to have children;
- Participants must be able to give their consent and must understand the risks associated with a participation in the study;
- There must be a signed and dated informed consent which was accepted by the local ethic committee
You may not qualify if:
- Existent pregnancy including ectopic pregnancy;
- Identification of other causes for the discomfort;
- Chronic diseases, except endometriosis, which require continuous pain therapy;
- Previous application of GnRH analogues 6 month prior to study;
- Concurrent use of systemic corticosteroids, antineoplastic agents and/or radiation;
- Planned additional general surgical procedures during the operation for removal of the endometriotic lesions;
- Absence of endometriosis at laparoscopy;
- Partial resection of the bowel or urinary bladder for removal of endometriosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pius-Hospital, Department of Gynecology, Obstetrics and Gynecological Oncology, Carl von Ossietzky University
Oldenburg, Lower Saxony, 26121, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rudy L De Wilde, Professor
Pius-Hospital Oldenburg, Department of Gynecology, Obstetrics and Gynecological Oncology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor Dr. Dr. med.
Study Record Dates
First Submitted
April 15, 2014
First Posted
June 18, 2014
Study Start
May 1, 2015
Primary Completion
May 1, 2017
Study Completion
May 1, 2017
Last Updated
November 3, 2015
Record last verified: 2015-11